Poorer nations still lack access to world ’s key antibiotics

Only 54 of 166 assessed treatments have policies aiding use by low-income countries, says non-profit groupThe world ’s biggest drugs makers have pressed on in the fight against superbugs despite the pandemic, but millions of people in poorer countries, where the risk of drug-resistant infections is highest, are still missing out on key antibiotics.A report from the Access to Medicine Foundation, an Amsterdam-based non-profit group, shows that only 54 of 166 medicines and vaccines assessed are covered by an access strategy to make them available to low- and middle-income countries.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Pharmaceuticals industry Vaccines and immunisation Tuberculosis E coli Gonorrhoea World Health Organization Business Drug resistance Drugs Drugs policy Medical research Global development Science Netherlands World news Source Type: news